Spyre Therapeutics’ SPY001 Shows ‘Best-in-Class’ Potential in Ulcerative Colitis Trial, Shares Soar
Spyre Therapeutics, a prominent player in the inflammatory bowel disease (IBD) landscape, announced groundbreaking early...
Knowledge and News for the Global Fight Against Cancer.
Spyre Therapeutics, a prominent player in the inflammatory bowel disease (IBD) landscape, announced groundbreaking early...
This past February, the community of Sailfish Point in Stuart, Florida, once again convened for...
The global health landscape is witnessing a profound shift as menopause, long relegated to hushed...
The Centers for Disease Control and Prevention (CDC) has formally published a new charter for...
During Women’s History Month, the Cancer Research Institute (CRI) proudly shines a spotlight on the...
Shanghai-based Oricell Therapeutics, a burgeoning force in the biotechnology sector, has successfully closed a pre-initial...
Colorectal cancer (CRC), encompassing both colon and rectal cancers, represents a formidable challenge in modern...
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Lumanity’s Cancer Progress 2026, held on April 9th at the New York Genome Center, served...
The eight women highlighted by CRI represent a powerful continuum of courage, intellectual curiosity, and...